Abstract
Candida albicans is an opportunistic fungal agent which has become a highly prevalent and incident cause of disease, especially life-threatening in neutropenic, bone-marrow transplanted subjects with underlying malignant hemopathy1,2. An extensive experimental evidence demonstrates that this fungus, and materials extracted from it, can also be used to influence or modify multiple biologic functions3,4. A particular point of interest in the “Biological Response Modifier” (BRM)-activities of Candida, that make this microorganism quite particular in comparison to other more popular microbial immunomodulators (for instance, BCG), is that Candida is a human commensal. Thus, almost every normal subject is primed for immune response to candidal antigens, as shown by the presence in its serum of measurable, sometimes elevated, levels of specific antibodies, and positive cell-mediated response to Candida antigens 5,6. While generating restrictions to the use of certain fungal materials as immunomodulators (mostly concerning undesired hypersensitivity reactions) the human commensalism also tells us that Candida-induced immunomodulation may take place under natural conditions and can be easily amplified. A rather dramatic example of this amplification is the generation of LAK- like effectors following Candida vaccination of normal mice7 or exposure of peripheral blood mononuclear cells (PBMC) from normal human donors to a mannoprotein extract of C. albicans 8. Moreover, certain fungal products are potent recall antigens to probe the efficiency of the immune system, both in normal and pathological conditions9,10 Most of the BRM-effects of C. albicans are mediated by the glucan and the mannoprotein constituents of the fungal cell wall4. In this note, we will mostly address the latter components (hereafter referred to as MP), and will attempt to summarize some of our recent results on the immunogenic and immunomodulatory effects of a purified and chemically-characterized mannoprotein fraction (F2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
F. C. Odds, Candida infections: an overview, CRC Crit. Rev. Microbiol. 15:1 (1987).
R. Horn, B. Wong, T. E. Kiehn, and D. Armstrong, Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy, Rev. Infect. Dis. 7:646 (1985).
A. Cassone, P. Marconi, F. Bistoni, E. Mattia, G. Sbaraglia, E. Garaci, and E. Bonmassar, Immunoadjuvant effects of Candida albicans andits cell wall fractions in a mouse lymphoma model, Cancer Immunol. Immunother. 10:181 (1981).
A. Cassone, Cell wall of Candida albicans, its functions and impact on the host, Current Topics Med. Mycol., 3:249 (1989).
F. C. Odds, “Candida and candidosis”, Baillière Tindall, London (1988).
C. M. Ausiello, G. C. Spagnoli, M. Boccanera, I. Casalinuovo, E Malavasi, C. U. Casciani, and A. Cassone, Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions, J. Med. Microbiol. 22:195 (1986).
L. Scaringi, P. Cornacchione, E. Rosati, M. Boccanera, A. Cassone, E Bistoni, and P. Marconi, Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans, Cell. Immunol. 129:271 (1990).
C. M. Ausiello, C. Palma, G. C. Spagnoli, A. Piazza, C. U. Casciani, and A. Cassone, Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin- 2 activate killer cells, Cell. Immunol. 121:349 (1989).
C. M. Ausiello, C. Palma, A. Maleci, G. C. Spagnoli, C. Amici, G. Antonelli, C. U. Casciani, and A. Cassone. Cell-mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patients. Eur. J. Cancer, in press (1991).
I. Quinti, C. Palma, E. C. Guerra, M. J. Gomez, I. Mezzaroma, F. Aiuti and A. Cassone. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Exptl. Clin. Immunol., in press (1991).
A. Torosantucci, M. Boccanera, I. Casalinuovo, G. Pellegrini and A. Cassone. Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans. J. Gen. Microbiol. 136:1421 (1990).
A. Torosantucci, C. Palma, M. Boccanera, C. M. Ausiello, G. C. Spagnoli and A. Cassone. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. J. Gen. Microbiol. 136:2155 (1990).
E. W. Carrow, and J. Domer. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Infect. Immun. 49:172 (1985).
J. Domer, K. Elkins, D. Ennist and P. Baker. Modulation of immune responses by surface polysaccarides of Candida albicans. Rev. Infect. Dis. 10:419 (1988).
C. F. Cuff, C. M. Rogers, B. J. Lamb, and T. J. Rogers. Induction of suppressor cells in vitro by Candida albicans. Cell. Immunol. 100:47 (1986).
C. D. Wright, M. J. Herron, G. R. Gray, B. Holmes, and R. D. Nelson. Influence of yeast mannan on human neutrophil functions: inhibition of release of mieloperoxidase related to carbohydrate-binding properties of the enzyme. Infect. Immun. 32:731 (1981).
R. Podzorski, G. R. Gray and R. D. Nelson. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in in vitro. J. Immunol. 144:707 (1990).
J. Tollemar, O. Ringdèn, and K. Holmberg Candida albicans: mannan and protein activation of cells from various human lymphoid organs. Scand. J. Immunol. 30:473 (1989).
A. L. Luzzati, E. Giacomini, A. Torosantucci, L. Giordani and A. Cassone. A mannoprotein constituent of Candida albicans cooperates with antigenic in the induction of a specific primary antibody response in cultures of human lymphocytes. J. Biol. Regul. Horn. Agents. 4:142 (1990).
A. Vecchiarelli, M. Puliti, A. Torosantucci, A. Cassone and F. Bistoni. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell. Immunol. 134:65 (1991).
J. Y. Djeu and D. Kay-Blanchard. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J. Immunol. 139:2761 (1987).
A. Saxena and R. Calderone. Purification and characterization of the extracellular C3d-binding protein of Candida albicans. Infect. Immun. 58:309 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cassone, A., Torosantucci, A., Palma, C., Gomez, M.J., Ausiello, C.M., Djeu, J.Y. (1992). Cell Wall Constituents of Candida Albicans as Biological Response Modifiers. In: Goldstein, A.L., Garaci, E. (eds) Combination Therapies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3340-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3340-5_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6472-6
Online ISBN: 978-1-4615-3340-5
eBook Packages: Springer Book Archive